Personalized Medicine: Recent Progress in Cancer Therapy

Area of Science:

• Oncology
• Translational Research
• Genomics

Background:

• Cancer treatment has shifted from organ-centric to molecularly-driven personalized approaches.
• Next-generation sequencing and RNA sequencing enhance detection of predictive molecular alterations.
• Molecular alterations (mutations, amplifications, fusions) impact cancer treatment in localized and metastatic settings.

Purpose of the Study:

• To critically analyze the evolution of cancer treatment towards a precision medicine approach.
• To highlight recent successes and unexpected failures in precision oncology.
• To discuss the role of molecular tumor boards in addressing treatment complexities.

Main Methods:

• Review of translational research advancements in oncology.
• Analysis of the impact of molecular profiling on treatment selection.
• Discussion of challenges in identifying driver mutations and managing tumor heterogeneity.

Main Results:

• Personalized treatment strategies based on molecular profiling have emerged.
• Basket trials targeting specific molecular alterations are increasingly common.
• Complexity of cancer cells and tumor heterogeneity pose significant challenges to targeted therapy efficacy.

Conclusions:

• Precision medicine represents a major advance in cancer treatment.
• Multidisciplinary approaches, such as molecular tumor boards, are crucial for optimizing patient selection and treatment.
• Continued research is needed to overcome limitations and improve outcomes in precision oncology.